ASCVD Risk Calculator
Free ASCVD risk calculator using the 2013 Pooled Cohort Equations. Estimate your 10-year heart attack and stroke risk, heart age, lifetime risk, and what-if scenarios for risk reduction.
The PCE was developed using White and African American cohorts. For other ethnicities, the White coefficients are used as the closest approximation.
Top number from your BP reading
Risk Factors
10-Year ASCVD Risk
5.4%
Your 10-year ASCVD risk is 5–7.5%. Discuss risk-enhancing factors with your clinician.
Key Metrics
Heart age, optimal benchmark, and lifetime risk at a glance
Heart Age
59yrs
+4 vs actual age
Lifetime Risk*
46%
*For a 50-year-old with your risk profile
Optimal Risk
3.6%
10-Year Risk
5.4%
What If You Changed...
See how modifying risk factors could reduce your 10-year risk
Toggle smoking or diabetes inputs to see additional what-if scenarios.
ASCVD Risk Categories
2013 ACC/AHA guideline thresholds for statin therapy discussion
Source: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (Goff et al., Circulation 2014).
What Is ASCVD?
Understanding atherosclerotic cardiovascular disease
Atherosclerotic cardiovascular disease (ASCVD) is caused by plaque buildup in artery walls. It is the leading cause of death worldwide — approximately 17.9 million deaths per year (WHO).
How to Use This Calculator
5 steps to estimate your cardiovascular risk
Enter Demographics
Age (40–79), biological sex, and race/ethnicity. The equations use sex- and race-specific statistical models.
Enter Cholesterol
Total cholesterol and HDL-C from a lipid panel blood test. Toggle between mg/dL and mmol/L units.
Enter Blood Pressure
Systolic BP (top number) and whether you're on antihypertensive medication.
Toggle Risk Factors
Indicate diabetes status and current smoking status.
Review Results
See your 10-year risk, heart age, and what-if scenarios for risk reduction. For ages 40–59, a lifetime risk estimate is also shown.
The Pooled Cohort Equations (PCE)
The validated statistical model powering this calculator
Published in 2013 by the ACC/AHA, the PCE uses Cox proportional hazards regression from four landmark cohort studies:
ARIC
Atherosclerosis Risk in Communities
CARDIA
Coronary Artery Risk Development
CHS
Cardiovascular Health Study
FHS
Framingham Heart Study
9 inputs across 4 sex/race-specific models:
Formula
Risk = 1 − S₀exp(ΣβᵢXᵢ − μ)
S₀ = baseline 10-year survival | βᵢ = regression coefficients | Xᵢ = ln-transformed risk factors | μ = population mean
Reference: Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation 2014;129(25 Suppl 2):S49–S73.
ASCVD Risk Categories & Actions
ACC/AHA guideline thresholds for preventive therapy
Continue healthy lifestyle. Statins generally not recommended unless risk-enhancing factors present (family history of premature ASCVD, LDL-C ≥ 160).
Discuss risk-enhancing factors: family history, metabolic syndrome, elevated CRP or Lp(a), South Asian ancestry. Consider CAC scoring.
A clinician-patient discussion about moderate-intensity statin therapy is reasonable. CAC scoring can help guide the decision — a CAC of 0 may favor deferral.
A clinician-patient discussion about statin therapy is strongly recommended. The intensity and any additional therapies should be individualized based on your full clinical profile.
How to Reduce Your ASCVD Risk
Evidence-based strategies with quantified impact
Risk begins dropping within weeks. Equals non-smoker risk within 5–15 years.
Target < 130/80 mmHg. Each 10 mmHg SBP drop lowers risk significantly.
Statins first-line. Every 39 mg/dL LDL-C reduction lowers risk ~22%.
Target HbA1c < 7%. SGLT2i and GLP-1a have proven cardiovascular benefits.
150+ min/week moderate-intensity aerobic activity per AHA guidelines.
Mediterranean or DASH diet. Emphasize fruits, vegetables, whole grains, fish.
Risk reduction percentages are approximate ranges from published clinical trials and meta-analyses. Individual results vary based on baseline risk, age, and adherence.
Statin Therapy Quick Guide
Dosing intensity based on your ASCVD risk level
| Intensity | LDL-C Reduction | Examples |
|---|---|---|
High | ≥ 50% | Atorvastatin 40–80 mg, Rosuvastatin 20–40 mg |
Moderate | 30–49% | Atorvastatin 10–20 mg, Rosuvastatin 5–10 mg, Simvastatin 20–40 mg |
Low | < 30% | Simvastatin 10 mg, Pravastatin 10–20 mg, Lovastatin 20 mg |
Limitations & Important Notes
What this calculator can and cannot tell you
Age range
Validated for ages 40–79 without pre-existing ASCVD. For younger adults, consider lifetime risk. For 80+, use clinical judgment.
Race & ethnicity
Specific models for White and African American populations. For Hispanic, Asian, or other groups, White coefficients are used — may be less accurate. The 2023 PREVENT model is race-agnostic.
Potential overestimation
Studies (MESA, Rotterdam) suggest PCE may overestimate risk by 20–60% in some groups. CAC scoring can reclassify up to 50% of intermediate-risk patients.
Missing factors
Does not account for family history, BMI, kidney function (eGFR), inflammatory markers (CRP), lipoprotein(a), or South Asian ancestry.
Medical disclaimer: This calculator is an educational tool based on the 2013 ACC/AHA Pooled Cohort Equations. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for cardiovascular risk assessment and treatment decisions.
Frequently Asked Questions
Common questions and detailed answers
Embed ASCVD Risk Calculator
Add this calculator to your website or blog for free.
You Might Also Like
Related calculators from other categories
Last updated Apr 3, 2026